Illumina Looks To Duck DNA Rival's Renewed Antitrust Case
By Matthew Perlman · July 6, 2026, 5:16 PM EDT
Illumina told a California federal court an antitrust case from DNA sequencing startup Element Biosciences should be tossed for good because it continues to attack legitimate discounts that do nothing to...
To view the full article, register now.